ALS-FTLD associated mutations of SQSTM1 impact on Keap1-Nrf2 signalling

The transcription factor Nrf2 and its repressor protein Keap1 play key roles in the regulation of antioxidant stress responses and both Keap1-Nrf2 signalling and oxidative stress have been implicated in the pathogenesis of the ALS-FTLD spectrum of neurodegenerative disorders. The Keap1-binding partn...

Full description

Bibliographic Details
Main Authors: Goode, Alice, Rea, Sarah, Sultana, Melanie, Shaw, Barry, Searle, Mark S., Layfield, Robert
Format: Article
Published: Elsevier 2016
Subjects:
Online Access:https://eprints.nottingham.ac.uk/36058/
_version_ 1848795214516322304
author Goode, Alice
Rea, Sarah
Sultana, Melanie
Shaw, Barry
Searle, Mark S.
Layfield, Robert
author_facet Goode, Alice
Rea, Sarah
Sultana, Melanie
Shaw, Barry
Searle, Mark S.
Layfield, Robert
author_sort Goode, Alice
building Nottingham Research Data Repository
collection Online Access
description The transcription factor Nrf2 and its repressor protein Keap1 play key roles in the regulation of antioxidant stress responses and both Keap1-Nrf2 signalling and oxidative stress have been implicated in the pathogenesis of the ALS-FTLD spectrum of neurodegenerative disorders. The Keap1-binding partner and autophagy receptor SQSTM1/p62 has also recently been linked genetically to ALS-FTLD, with some missense mutations identified in patients mapping within or close to its Keap1-interacting region (KIR, residues 347–352) of SQSTM1/p62. Here we report the effects on protein function of four different disease associated mutations of SQSTM1/p62 which affect the KIR region. Only mutations mapping precisely to the KIR (P348L and G351 A) were associated with a loss of Keap1 binding in co-immunoprecipitations comparable to wild-type SQSTM1/p62. These selective effects on Keap1 recognition were entirely rational based on protein structural models. Consistent with impaired Keap1 binding, the P348L and G351A KIR mutants showed reduced ability to activate Nrf2 signalling compared to wild-type SQSTM1/p62 in antioxidant response element (ARE)-luciferase reporter assays. The results suggest that SQSTM1 mutations within the KIR of SQSTM1/p62 contribute to aetiology of some cases of ALS-FTLD through a mechanism involving aberrant expression or regulation of oxidative response genes.
first_indexed 2025-11-14T19:28:32Z
format Article
id nottingham-36058
institution University of Nottingham Malaysia Campus
institution_category Local University
last_indexed 2025-11-14T19:28:32Z
publishDate 2016
publisher Elsevier
recordtype eprints
repository_type Digital Repository
spelling nottingham-360582020-05-04T18:18:18Z https://eprints.nottingham.ac.uk/36058/ ALS-FTLD associated mutations of SQSTM1 impact on Keap1-Nrf2 signalling Goode, Alice Rea, Sarah Sultana, Melanie Shaw, Barry Searle, Mark S. Layfield, Robert The transcription factor Nrf2 and its repressor protein Keap1 play key roles in the regulation of antioxidant stress responses and both Keap1-Nrf2 signalling and oxidative stress have been implicated in the pathogenesis of the ALS-FTLD spectrum of neurodegenerative disorders. The Keap1-binding partner and autophagy receptor SQSTM1/p62 has also recently been linked genetically to ALS-FTLD, with some missense mutations identified in patients mapping within or close to its Keap1-interacting region (KIR, residues 347–352) of SQSTM1/p62. Here we report the effects on protein function of four different disease associated mutations of SQSTM1/p62 which affect the KIR region. Only mutations mapping precisely to the KIR (P348L and G351 A) were associated with a loss of Keap1 binding in co-immunoprecipitations comparable to wild-type SQSTM1/p62. These selective effects on Keap1 recognition were entirely rational based on protein structural models. Consistent with impaired Keap1 binding, the P348L and G351A KIR mutants showed reduced ability to activate Nrf2 signalling compared to wild-type SQSTM1/p62 in antioxidant response element (ARE)-luciferase reporter assays. The results suggest that SQSTM1 mutations within the KIR of SQSTM1/p62 contribute to aetiology of some cases of ALS-FTLD through a mechanism involving aberrant expression or regulation of oxidative response genes. Elsevier 2016-10-02 Article PeerReviewed Goode, Alice, Rea, Sarah, Sultana, Melanie, Shaw, Barry, Searle, Mark S. and Layfield, Robert (2016) ALS-FTLD associated mutations of SQSTM1 impact on Keap1-Nrf2 signalling. Molecular and Cellular Neuroscience, 76 . pp. 52-58. ISSN 1044-7431 ALS-FTLD; SQSTM1/p62; Keap1-Nrf2; Oxidative stress http://www.sciencedirect.com/science/article/pii/S1044743116301191 doi:10.1016/j.mcn.2016.08.004 doi:10.1016/j.mcn.2016.08.004
spellingShingle ALS-FTLD; SQSTM1/p62; Keap1-Nrf2; Oxidative stress
Goode, Alice
Rea, Sarah
Sultana, Melanie
Shaw, Barry
Searle, Mark S.
Layfield, Robert
ALS-FTLD associated mutations of SQSTM1 impact on Keap1-Nrf2 signalling
title ALS-FTLD associated mutations of SQSTM1 impact on Keap1-Nrf2 signalling
title_full ALS-FTLD associated mutations of SQSTM1 impact on Keap1-Nrf2 signalling
title_fullStr ALS-FTLD associated mutations of SQSTM1 impact on Keap1-Nrf2 signalling
title_full_unstemmed ALS-FTLD associated mutations of SQSTM1 impact on Keap1-Nrf2 signalling
title_short ALS-FTLD associated mutations of SQSTM1 impact on Keap1-Nrf2 signalling
title_sort als-ftld associated mutations of sqstm1 impact on keap1-nrf2 signalling
topic ALS-FTLD; SQSTM1/p62; Keap1-Nrf2; Oxidative stress
url https://eprints.nottingham.ac.uk/36058/
https://eprints.nottingham.ac.uk/36058/
https://eprints.nottingham.ac.uk/36058/